Advanced Strategies and Methods for Safety Testing Next-Generation Therapeutics
As more cell and gene therapies advance in development, toxicology assessment of these therapies is evolving to encompass new testing strategies and embrace new endpoints to assess potential physiological changes.
As an expert contract research organization (CRO), AmplifyBio leverages decades of experience to create modern commercial drug development solutions. From CRO and preclinical CRO needs to cell and gene therapy and advanced therapy testing, our accredited team designs innovative paths to produce globally recognized studies, services, and more.
